CME GROUP INC. 8-K 2016
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
CME Group Inc.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Duffy Employment Agreement
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On December 7, 2016, the Board amended the Company’s Amended and Restated Bylaws (the "Bylaws") to reflect Mr. Duffy’s role as Chairman and Chief Executive Officer as well as to add certain qualifications for members of the Board of Directors.
Item 9.01 Financial Statements and Exhibits.
Copies of the following exhibits are attached to this report and are incorporated herein by reference as though each was fully set forth herein:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.